We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25B
AUM Growth
+$2.37B
(+11%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$783M |
| 2 |
Genuine Parts
GPC
|
+$573M |
| 3 |
Paychex
PAYX
|
+$431M |
| 4 |
Monster Beverage
MNST
|
+$119M |
| 5 |
Northern Trust
NTRS
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$804M |
| 2 |
Accenture
ACN
|
+$118M |
| 3 |
Sysco
SYY
|
+$76.9M |
| 4 |
Apple
AAPL
|
+$76.7M |
| 5 |
NetApp
NTAP
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.58% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BERY
1026
DELISTED
Berry Global Group, Inc.
BERY
| $169K | ﹤0.01% |
3,804
-1,739
| -31% | -$76.4K |
|
|
JBTM
1027
JBT Marel
JBTM
$7.37B
| $168K | ﹤0.01% |
1,420
| – | – |
|
1028
OGE Energy
OGE
$10.2B
| $167K | ﹤0.01% |
4,599
-5,981
| -57% | -$218K |
|
1029
CarParts.com
PRTS
$39.7M
| $167K | ﹤0.01% |
10,807
| – | – |
|
|
BPY
1030
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $167K | ﹤0.01% |
8,000
+3,275
| +69% | +$65.4K |
|
1031
Scansource
SCSC
$1.13B
| $166K | ﹤0.01% |
4,178
+116
| +3% | +$4.75K |
|
|
VE
1032
DELISTED
VEOLIA ENVIRONNEMENT
VE
| $164K | ﹤0.01% |
+8,227
| New | +$164K |
|
1033
Nuveen Global High Income Fund
JGH
$349M
| $163K | ﹤0.01% |
10,492
| – | – |
|
1034
Sunstone Hotel Investors
SHO
$2.2B
| $163K | ﹤0.01% |
9,974
-3,740
| -27% | -$61.7K |
|
1035
National Grid
NGG
$81.6B
| $161K | ﹤0.01% |
+3,536
| New | +$168K |
|
1036
Baker Hughes
BKR
$60.1B
| $159K | ﹤0.01% |
4,717
-151
| -3% | -$5K |
|
1037
Western Union
WU
$2.55B
| $159K | ﹤0.01% |
8,415
+241
| +3% | +$4.68K |
|
1038
Prudential
PUK
$36.6B
| $157K | ﹤0.01% |
+3,533
| New | +$156K |
|
|
ARRY
1039
DELISTED
Array Biopharma Inc
ARRY
| $157K | ﹤0.01% |
10,385
+3,650
| +54% | +$55.9K |
|
|
HOME
1040
DELISTED
At Home Group Inc.
HOME
| $156K | ﹤0.01% |
4,980
+1,795
| +56% | +$63.3K |
|
1041
Factset
FDS
$9.46B
| $155K | ﹤0.01% |
700
| – | – |
|
1042
Omnicell
OMCL
$1.89B
| $155K | ﹤0.01% |
2,166
-754,800
| -100% | -$47.5M |
|
1043
Huron Consulting
HURN
$1.89B
| $151K | ﹤0.01% |
3,076
| – | – |
|
|
EON
1044
DELISTED
E.ON AG ADS (REPTG 1/3 ORD SHS)
EON
| $151K | ﹤0.01% |
14,841
+11,886
| +402% | +$121K |
|
1045
Artisan Partners
APAM
$2.86B
| $150K | ﹤0.01% |
4,635
| – | – |
|
1046
RELX
RELX
$62.3B
| $149K | ﹤0.01% |
+7,162
| New | +$156K |
|
1047
UBS Group
UBS
$172B
| $149K | ﹤0.01% |
9,549
+1,633
| +21% | +$25.7K |
|
1048
Aecom
ACM
$9.12B
| $148K | ﹤0.01% |
4,549
-1,824
| -29% | -$60.1K |
|
1049
TechnipFMC
FTI
$29.9B
| $148K | ﹤0.01% |
6,400
-2,699
| -30% | -$61.2K |
|
|
BT
1050
DELISTED
BT Group plc (ADR)
BT
| $148K | ﹤0.01% |
+10,061
| New | +$149K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.
- Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
- Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
- Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
- Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
- Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
- Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
- Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.
Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.